The reduction of surgical wound infections by topical cephaloridine: a controlled clinical trial.
D001439:Bacteroides / Q000302:isolation & purification; D002509:Cephaloridine / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003016:Clostridium perfringens / Q000302:isolation & purification; D004754:Enterobacter / Q000302:isolation & purification; D013293:Enterococcus faecalis / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D009765:Obesity / Q000150:complications; D011511:Proteus / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D013997:Time Factors
D002509:Cephaloridine